From my colleague Adam Feuerstein: Biogen and Stoke Therapeutics have signed a partnership agreement to co-develop and sell ...

J&J said it found no immediate procedure-related causes from the atrial fibrillation therapy but that risks can escalate if a ...

At a time when many life sciences companies are shrinking their workforce, Vertex Pharmaceuticals Inc. has once again grown ...

The NIH says funding cuts would save it billions of dollars a year. D.C.-area industry and academic leaders say it would cripple R&D.

The biotech industry is on a stable growth path, owing to the integration of modern technologies and rapid drug discoveries.

Though most biopharma investment is in two states, follow this model to bring the research—and investments—elsewhere.

Shift Bioscience, a biotech company using an AI powered virtual cell to fight age-related diseases, today announced the establishment of a new North American team and facilities to advance development ...

Biogen and Stoke Therapeutics have agreed to collaborate on Stoke's proposed zorevunersen treatment for the severe genetic epilepsy Dravet syndrome in a deal potentially worth hundreds of millions of ...

New England auto giant Herb Chambers Companies has been acquired by the publicly traded Asbury Automotive Group in a $1.34 ...

Stoke Therapeutics Inc. and Biogen Inc. said Tuesday they are entering a collaboration to develop and commercialize a ...

Apple opened a massive new health study last week that will track data from hundreds of thousands of iPhone owners who volunteer to participate. The goal is to uncover previously unseen connections ...

New England Biolabs Inc. reached a class settlement with workers who say they were wrongly forced to sell their company stock at an unfair price.